Dr. Christopher Jeffrey Charles Rodgman, MD

Dr. Rodgman practices at Jennifer W. Jones in Alexandria, Louisiana.

Dr. Rodgman's NPI, 1861635849, was assigned on April 7, 2009. Dr. Rodgman holds Louisiana license MD.205436.

Dr. Rodgman's primary practice is Jennifer W. Jones, at 5920 Coliseum Blvd, Alexandria, LA 71303-3714. The practice phone is (318) 443-9339.

Dr. Rodgman's primary practice is Jennifer W. Jones in Alexandria, Louisiana. Dr. Rodgman is also affiliated with Willis Knighton North. The medical group on file is Longleaf Hospital. Dmand AI also links Dr. Rodgman to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodgman practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Rodgman's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Rodgman is licensed in Louisiana.

CMS data shows 141 Medicare services from Dr. Rodgman across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $11,586 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Dr. Rodgman in 2024. 75% of them have anxiety, and 75% have depression. 45% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rodgman's median patient age at 45, with 48% women.

In 2024, Dr. Rodgman wrote 2,405 Medicare Part D claims for 90 patients. 90% of them were for generic drugs. CMS names the drug for 2,182 of them, across 53 drugs with 11 or more claims each, at $260,005 in total drug cost. In 2023, CMS named 2,319 claims across 58 drugs.

Dr. Rodgman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rodgman as offering telehealth.

Dmand AI links 7 papers to Dr. Rodgman, published from 2010 to 2019. 2014 was the busiest year, with 2. The most frequent topics are Adrenergic alpha-2 Receptor Agonists, Cannabinoid Receptor Agonists and Dronabinol. Dr. Rodgman's most frequent co-authors are Mariyah Zafar Hussain, MD, Thomas Richard Kosten, MD and David Mathai, MD.

CMS Open Payments shows 181 general payments to Dr. Rodgman from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $565.